Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report) was the target of a large drop in short interest in March. As of March 31st, there was short interest totalling 1,555,700 shares, a drop of 7.7% from the March 15th total of 1,684,700 shares. Based on an average daily trading volume, of 1,083,800 shares, the short-interest ratio is currently 1.4 days.
Elite Pharmaceuticals Trading Up 3.7 %
ELTP opened at $0.14 on Wednesday. The stock has a 50-day moving average of $0.16 and a 200 day moving average of $0.15. The company has a current ratio of 1.94, a quick ratio of 1.19 and a debt-to-equity ratio of 0.08. Elite Pharmaceuticals has a 12 month low of $0.03 and a 12 month high of $0.21. The firm has a market cap of $149.56 million, a P/E ratio of 14.01 and a beta of -0.16.
Elite Pharmaceuticals Company Profile
See Also
- Five stocks we like better than Elite Pharmaceuticals
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Checking in with 5 Bitcoin Stocks Ahead of Bitcoin’s Halving
- Investing In Automotive Stocks
- Commercial Banks Could Be Back in Play, Led by Bank of America
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.